Tyler Van Buren analyst TD COWEN

Currently, out of the existing stock ratings of Tyler Van Buren - 237 which are a Buy (79.26%), 57 which are a Hold (19.06%), 5 which are a Sell (1.67%)

Tyler Van Buren

Work Performance Price Targets & Ratings Chart

Analyst Tyler Van Buren works at TD COWEN and is covering the Healthcare sector with 627 price targets and ratings displayed on 46 stocks. Previously, Tyler Van Buren worked at PIPER SANDLER.

Tyler Van Buren's average stock forecast success ratio is 34.39% with an average time for price targets to be met of 119.38 days.

Most recent stock forecast was given on MRNA, Moderna at 04-Aug-2023.

Wall Street Analyst Tyler Van Buren

Analyst best performing recommendations are on RCKT (ROCKET PHARMACEUTICALS).
The best stock recommendation documented was for RCKT (ROCKET PHARMACEUTICALS) at 12/8/2020. The price target of $50 was fulfilled within 1 day with a profit of $17.97 (56.1%) receiving and performance score of 561.04.

Average potential price target upside

ADVM Adverum Biotechnologies AGIO Agios Pharmaceuticals ALLO Allogene Therapeutics APTO Aptose Biosciences BGNE BeiGene, Ltd BHVN Biohaven Pharmaceutical Holding Company Ltd BLUE bluebird bio GILD Gilead Sciences GOSS HARP Harpoon Therapeutics INCY yte IONS Ionis Pharmaceuticals MRNA Moderna MRTX Mirati Therapeutics NKTR Nektar Therapeutics OTIC Otonomy RCKT Rocket Pharmaceuticals SRPT Sarepta Therapeutics AERI Aerie Pharmaceuticals ARVN Arvinas REGN Regeneron Pharmaceuticals TBPH Theravance Biopharma BBIO BridgeBio Pharma BCRX BioCryst Pharmaceuticals CRNX Crinetics Pharmaceuticals FATE Fate Therapeutics KURA Kura Oncology MGTX NRIX Nurix Therapeutics OVID Ovid Therapeutics OYST PRAX Praxis Precision Medicines PTE PolarityTE CRSP CRISPR Therapeutics AG NEOS TPTX Turning Point Therapeutics CBAY CymaBay Therapeutics CBIO LPTX ALGS DCPH Deciphera Pharmaceuticals PSTX EIDX IMCR NLTX TYRA

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$4.39 (272.67%)


16 days ago

4/7 (57.14%)

$1.84 (83.32%)




$2.39 (148.45%)


1 months 10 days ago

1/3 (33.33%)

$1.46 (113.82%)




$0.39 (24.22%)


2 years 1 months 29 days ago

3/5 (60%)

$3.07 (29.73%)




2 years 1 months 29 days ago

2/2 (100%)

$7.53 (88.83%)




$1.39 (86.34%)


2 years 1 months 29 days ago

1/2 (50%)

$2.74 (33.46%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Tyler Van Buren is most bullish on?

Potential upside of $53.38 has been obtained for REGN (REGENERON PHARMACEUTICALS)

Which stock is Tyler Van Buren is most reserved on?

Potential downside of $21.47 has been obtained for MRNA (MODERNA)

What Year was the first public recommendation made by Tyler Van Buren?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart